06 Apr 2017
N+1 Singer - Abzena - £25m Placing to fund transformational growth
The proposed £25m (gross) capital raise will fund a number of potentially transformational growth initiatives, including a significant increase in manufacturing capability at the San Diego facility, and accelerate Abzena’s progress towards sustainable profitability. We continue to view Abzena as an emerging leader in the biopharmaceuticals services space, and reiterate a highly positive stance.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Abzena - £25m Placing to fund transformational growth
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
06 Apr 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
The proposed £25m (gross) capital raise will fund a number of potentially transformational growth initiatives, including a significant increase in manufacturing capability at the San Diego facility, and accelerate Abzena’s progress towards sustainable profitability. We continue to view Abzena as an emerging leader in the biopharmaceuticals services space, and reiterate a highly positive stance.